They found that people who had been prescribed these drugs more frequently, or who took multiple types, had a higher risk of ...

Parkinson’s disease is a neurodegenerative disease that causes nerve cells in the brain to die leading to impaired movement, ...

In a recent study, talk therapy in Parkinson’s disease led to significant improvement in patients' well-being, ...

Researchers at Karolinska Institutet have discovered new insights into brain changes in Parkinson's disease using advanced ...

From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

Danish film director Lars von Trier has been admitted to a care facility for Parkinson’s disease, his producer said Wednesday ...

Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...

The glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease severity.

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...

Dec. 18, 2024 — Dancing lowers the depression associated with Parkinson's disease, and the benefits can be seen in multiple ways, a new study ... Nov. 19, 2024 — A recently published study ...

Daniel Barenboim, the eminent conductor and pianist who stepped back from engagements in recent years citing health concerns, ...